[{"@timestamp": "2022-01-08T02:11:24.008839Z", "project": {"build": {}, "deployment": {}, "publications": [], "summary": {"description": true}, "website": {"access_time": 685, "bioschemas": false, "copyright": false, "https": true, "last_check": "2022-01-08T02:11:23.948853Z", "license": false, "operational": 200, "ssl": true, "last_month_access": {"average_access_time": 745, "downtime_days": 0, "uptime_days": 30}, "half_year_stat": [{"days": 1, "serie": [1], "status": 503}, {"days": 182, "serie": [65, 117], "status": 200}], "ssl_err": null}}, "@id": "https://openebench.bsc.es/monitor/metrics/tcga-lgg", "@nmsp": null, "@type": "metrics", "@license": "https://creativecommons.org/licenses/by/4.0/"}, {"@timestamp": "2022-01-08T19:38:12.543100Z", "project": {"build": {}, "deployment": {}, "publications": [{"entries": [{"title": "Engrailed 1 overexpression as a potential prognostic marker in Lower Grade Glioma.", "year": 2019, "ref_count": 21, "cit_count": 1, "refs": [{"count": 1, "year": 1997}, {"count": 1, "year": 2003}, {"count": 1, "year": 2004}, {"count": 1, "year": 2008}, {"count": 2, "year": 2009}, {"count": 1, "year": 2010}, {"count": 1, "year": 2011}, {"count": 2, "year": 2012}, {"count": 1, "year": 2014}, {"count": 2, "year": 2015}, {"count": 4, "year": 2016}, {"count": 1, "year": 2017}, {"count": 3, "year": 2018}], "citations": [{"count": 1, "year": 2020}], "doi": "10.7717/peerj.7414", "pmid": "31576231", "pmcid": "PMC6752186"}]}], "summary": {"description": true}, "website": {"access_time": 685, "bioschemas": false, "copyright": false, "https": true, "last_month_access": {"average_access_time": 747}, "license": false, "operational": 200, "ssl": null, "ssl_err": null, "half_year_stat": [{"days": 65, "serie": [65], "status": 200}]}}, "@id": "https://openebench.bsc.es/monitor/metrics/biotools:tcga-lgg/undefined/portal.gdc.cancer.gov", "@nmsp": "biotools", "@type": "metrics", "@license": "https://creativecommons.org/licenses/by/4.0/"}]